Tonix Pharmaceuticals Q4 EPS $(0.56) Beats $(0.86) Estimate; Cash and Cash Equivalents Of Approximately $120.2M
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.86) by 34.88 percent. This is a 73.08 percent increase over losses of $(2.08) per share